Cart
sales@molnova.com
TG6-129
CAS No. 1164464-14-5
TG6-129( TG6 129 | TG6129 )
Catalog No. M27930 CAS No. 1164464-14-5
TG6-129 is an antagonist of the EP2 receptor. TG6-129 suppresses PGE2-induced elevation of cAMP in cells expressing EP2 with an IC50 value of 1.6 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 339 | In Stock |
|
| 5MG | 240 | In Stock |
|
| 10MG | 427 | In Stock |
|
| 25MG | 702 | In Stock |
|
| 50MG | 918 | In Stock |
|
| 100MG | 1293 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2623 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTG6-129
-
NoteResearch use only, not for human use.
-
Brief DescriptionTG6-129 is an antagonist of the EP2 receptor. TG6-129 suppresses PGE2-induced elevation of cAMP in cells expressing EP2 with an IC50 value of 1.6 μM.
-
DescriptionTG6-129 is an antagonist of the EP2 receptor. TG6-129 suppresses PGE2-induced elevation of cAMP in cells expressing EP2 with an IC50 value of 1.6 μM. TG6-129 reduces the expression of COX-2, IL-1β, IL-6, IL-12, IL-23 and TNF-α induced by the EP2-selective agonist butaprost in P388D1 macrophages.
-
In Vitro——
-
In Vivo——
-
SynonymsTG6 129 | TG6129
-
PathwayGPCR/G Protein
-
TargetProstaglandin Receptor
-
Recptorestrogen receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1164464-14-5
-
Formula Weight491.57
-
Molecular FormulaC20H18FN5O3S3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCc1nnc(NS(=O)(=O)c2ccc(NC(=S)NC(=O)\C=C\c3ccc(F)cc3)cc2)s1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Guo S, et al. GLL398, an oral selective estrogen receptor degrader (SERD), blocks tumor growth in xenograft breast cancer models. Breast Cancer Res Treat. 2020;180(2):359-368.
molnova catalog
related products
-
Carboprost trometham...
Carboprost tromethamine is the synthetic 15-methyl analogue of prostaglandin F2α and it can effectively promote law contraction of the uterus and significantly reduce the amount of bleeding during and after delivery.Carboprost tromethamine has been accounted for to be 84-96% successful in the treatment of persistent hemorrhage because of uterine atony.
-
Evatanepag
Evatanepag is an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation with EC50 of 0.3 nM.
-
(+)-Fluprostenol
(+)-Fluprostenol, an analogue of prostaglandin F2 alpha, is a prostaglandin F2α receptor PTGFR agonist and decreases the expression of Oviductal glycoprotein 1 (OVGP1).
